Robert Stone Dow Neurobiology Laboratories, Legacy Research, Portland, OR 97232, USA.
Curr Neuropharmacol. 2009 Sep;7(3):195-206. doi: 10.2174/157015909789152191.
The adenosine A(2A) receptor (A(2A)R) is in the center of a neuromodulatory network affecting a wide range of neuropsychiatric functions by interacting with and integrating several neurotransmitter systems, especially dopaminergic and glutamatergic neurotransmission. These interactions and integrations occur at multiple levels, including (1) direct receptor- receptor cross-talk at the cell membrane, (2) intracellular second messenger systems, (3) trans-synaptic actions via striatal collaterals or interneurons in the striatum, (4) and interactions at the network level of the basal ganglia. Consequently, A(2A)Rs constitute a novel target to modulate various psychiatric conditions. In the present review we will first summarize the molecular interaction of adenosine receptors with other neurotransmitter systems and then discuss the potential applications of A(2A)R agonists and antagonists in physiological and pathophysiological conditions, such as psychostimulant action, drug addiction, anxiety, depression, schizophrenia and learning and memory.
腺苷 A(2A)受体 (A(2A)R) 位于神经调节网络的中心,通过与多种神经递质系统相互作用和整合,特别是与多巴胺能和谷氨酸能神经传递,影响广泛的神经精神功能。这些相互作用和整合发生在多个层面,包括 (1) 细胞膜上的直接受体-受体交叉对话,(2) 细胞内第二信使系统,(3) 通过纹状体侧支或纹状体中间神经元的突触后作用,以及 (4) 基底神经节网络层面的相互作用。因此,A(2A)R 成为调节各种精神疾病的新靶点。在本综述中,我们将首先总结腺苷受体与其他神经递质系统的分子相互作用,然后讨论 A(2A)R 激动剂和拮抗剂在生理和病理生理条件下的潜在应用,如精神兴奋剂作用、药物成瘾、焦虑、抑郁、精神分裂症和学习记忆。